Immune effect of Traditional Chinese Medicine combined with transcatheter arterial chemoembolization in treatment of liver cancer: a meta-analysis
TCM combined with TACE for liver cancer can improve immune function. Additionally, the combination treatment can reduce the VEGF levels associated with inhibiting angiogenesis. Therefore, combining TCM with TACE offers advantages over TACE in treating liver cancer. The protocol has been registered with the International Prospective Register of Systematic Reviews (PROSPERO) ( https://www.crd.york.ac.uk/ ), registration number CRD420251011821.
Authors
- Xiaolin Liu (ORCID: https://orcid.org/0000-0002-4785-0657)
- Xiangxue Pan
- Liubing Lin (ORCID: https://orcid.org/0000-0001-6371-2142)
- Shasha Zhao
- Kehui Zhang
- Zongyao Wang
- Jian Wang
- Xiang Lv
- Shun Sheng
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Chengtou (China) (CN)
- Shanghai Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1186/s12885-026-15562-w
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00